Siemens Healthineers to Acquire Varian

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion....

MTMI Partners with Nautilus Medical Technologies

The Medical Technology Management Institute (MTMI), a division of The College of Health Care Professions, has announced a partnership with Nautilus Medical Technologies, developer of a cloud-based imaging sharing platform used by over a thousand health care providers...

Gillette Children’s Specialty Healthcare is the first U.S. hospital to image patients with EOSedge

EOS imaging, a provider of 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, has announced the first exams performed with EOSedge in the United States, at Gillette Children's Specialty Healthcare’s main campus...

Webinar on FDA’s Regulation of Face Masks and Surgical Masks during the COVID-19 Pandemic

On Tuesday, August 4, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the FDA’s regulation of face masks and surgical masks during the COVID-19 pandemic. This webinar will expand the scope of the respirator webinar series to...

People on the Move – October 7, 2019

By Matt Skoufalos

Joshua Milner

Joshua Milner has been named division chief of pediatric allergy, immunology, and rheumatology at Columbia University Vagelos College of Physicians and Surgeons and professor of pediatrics in the Institute for Genomic Medicine at Columbia University Irving Medical Center, both of New York, New York. Milner will also serve as chief of the allergy, immunology, and rheumatology services at New York-Presbyterian Morgan Stanley Children’s Hospital. Milner previously was a National Institutes of Health (NIH) physician-scientist at the National Institute of Allergy and Infectious Disease (NIAID). Milner is board-certified in allergy and immunology, has been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the Henry Kunkel Society.


Dr. Gary Curhan joins OM1

OM1 of Boston, Massachusetts named Gary Curhan its Chief Medical Officer.  Curhan is a practicing nephrologist in Boston, a part-time professor of medicine at Harvard Medical School, and part-time professor of Epidemiology at Harvard School of Public Health. Previously, Curhan was the editor-in-chief of the Clinical Journal of the American Society of Nephrology.


VIDA Diagnostics of Coralville, Iowa named Erkan Akyuz an independent member of its board of directors. Akyuz is president and CEO of both Rhapsody and Corepoint Health, previously served as president of medical imaging, workflow and care solutions for McKesson Technology Solutions, and was president and CEO of Vital Images. He has a master’s degree from the Naval Postgraduate School and an MBA degree from INSEAD.


Ceek Women’s Health of Portland, Oregon added Natalie Douglas and Wendy White to its board of directors. Douglas is the founder and chairman of Lucidity LLC, established healthcare services company IDIS, which was later sold, and led the turn-around of the UK-based Healthcare at Home. She is currently vice-chairman to US based Global Genes and a non-executive director to Draper and Dash.

White is the former Chief Patient Officer for Vitrisa Therapeutics, founded Siren Interactive Corporation, which was later sold to Dohmen Life Science Services, and currently serves as chair of global genes, chair emeritus for the Healthcare Businesswomen’s Association, and as an executive advisor to the Chicago Life Science Consortium.


AMCP of Alexandria, Virginia added Phil Bongiorno as VP of policy and government relations. Prior to joining AMCP, he was the executive director of the Home Care Association of America; he has been director of government relations for the Society of Thoracic Surgeons, senior director of government relations at the American Academy of Audiology, head of federal affairs and public health and scientific affairs at the College of American Pathologists, and director of the American Public Health Association.

Availity of Jacksonville, Florida named Frank J. Manzella its new SVP of Corporate Development & Strategy. Manzella was previously chief development officer of Press Ganey Associates and has been SVP of corporate development at Change Healthcare. He has bachelor’s, master’s, and juris doctotrate degrees from Georgetown University.


The Seattle, Washington-based Milliman, Inc. named Garry C. Simmons its director of business development for health and group benefits consulting services. Simmons was most recently SVP for health solutions at Aon, and has served on the board of directors of both the North Carolina Business Group on Health and the South Carolina Business Coalition on Health.


The Chicago, Illinois-based American Board of Medical Specialties named Julie Hubbard its CFO. Hubbard has been SVP of finance for Easter Seals, CFO and treasurer of the Spencer Foundation, and director of financial planning for Kraft.

She has an MBA in finance from the University of Chicago.


CNSI of Rockville, Maryland named David Adams its EVP and CFO. Adams joins CSNI from Endeavor Robotics, where he was CFO. He had been CFO at Tribalco, LLC and at the Services & Solutions Group of QinetiQ North America. He also has been VP of Finance at Science Applications International Corporation (SAIC), and holds an MBA from the State University of New York-Buffalo.


MediSpend of Portsmouth, New Hampshire has named Dave Cormack to its board of directors. Cormack is the current chairman at Curve Dental Software and vice-chairman of Scottish Premiership’s Aberdeen Football Club. He was president and chief executive officer at Brightree, and founded and developed Soft Systems Limited and After IQ Software bought Soft Systems, Cormack was its SVP of worldwide operations.


Gerald Levin

Dialyze Direct of Brooklyn, New York named former Time Warner and HBO CEO Gerald Levin its Chief Mission Officer and chairman of Dialyze Innovation Group. Levin is also the Executive Chairman of StartUp Health.


Angel Medical Systems Inc. of Eatontown, New Jersey created its medical advisory board. Members include:

  • Michael Gibson, MD Chairman, Harvard Medical School
  • David Holmes, MD Mayo Clinic College of Medicine
  • Mitchell Krucoff, MD Duke Medical School
  • David Wohns, MD Spectrum Health
  • Kelly Tucker, MD Orange County Heart Institute
  • Arthur Eberly, MD Prisma Health
  • Vishal Gupta, MD Ascension Borgess Hospital
  • Kimberly Skelding, MD Alabama Heart & Vascular Medicine
  • Ajay Kirtane, MD Columbia University Medical Center
  • Martin Leon, MD Columbia University Medical Center
  • Andrew Kaplan, MD Cardiovascular Associates of Mesa
  • Rishi Anand, MD Holy Cross Hospital


Ranndy Kellogg

The American Heart Association of Lake Forest, Illinois named Ranndy Kellogg, president and CEO of Omron Healthcare, to its Metro Chicago board of directors.

Kellogg is a longstanding AHA volunteer and co-chairman of the 25th Anniversary Chicago Heart Walk. He has an MBA from Northwestern University.


Primaria Health of Indianapolis, Indiana named Marty O’Neill its CEO and president. O’Neill was most recently a senior executive at Lahey Health System of Burlington, Massachusetts, and has held senior executive roles at Paragon Health in Newburgh, Indiana and The Heart Group in Evansville, Indiana.


Amy Fahrenkopf

The New York, New York-based Hospital for Special Surgery named Amy Fahrenkopf as its first General Manager and SVP. Her experience includes leadership roles at Highmark Blue Cross Blue Shield, Castlight Health, McKinsey & Co., and the U.S. Department of Veterans Affairs. Fahrenkopf comes to HSS from Socially Determined, a healthcare analytics firm in Washington, DC, where she was Chief Medical Officer and SVP for value-based strategy. She also has served on the medical staff at Boston Children’s Hospital and was an instructor in pediatrics at Harvard Medical School.


Centene Corporation of St. Louis, Missouri named David P. Thomas its EVP of markets. Thomas was regional SVP of Centene and president and CEO of its New York subsidiary, Fidelis Care. He succeeds the retiring Christopher D. Bowers.

Thomas Halloran, Fidelis Care EVP and CFO, has been appointed its interim CEO, as the company searches for a permanent CEO.


Apollo Medical Holdings of Alhambra, California named Matthew Mazdyasni to its board of directors and Brandon Sim its interim Chief Technology Officer. Mazdyasni provides consulting and advisory services to various companies, including Apollo Medical Holdings, and was previously the EVP, Chief Administrative Officer, and CFO of HealthCare Partners Holding, LLC. He is a current member of the Health Advisory Board of the USC Sol Price School of Public Policy and holds a master’s in accounting from the University of Kentucky. Sim has been a Quantitative Researcher at Citadel Securities since 2015, was Chief Technology Officer at Theratech, and holds a master’s degree in computer science and engineering from Harvard University.



Submit a Comment

Your email address will not be published. Required fields are marked *